FIROUZEH RAD: Open Payments
NPI 1023746096 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 6 payments from 4 companies in 2025. Trend: 2023 $114 · 2024 $675 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $233 |
| Eisai Inc. | 1 | $84 |
| Corcept Therapeutics | 1 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: Livdelzi, Epclusa, Leqembi, Korlym, LIVTENCITY.
Industry payments across TX — which companies pay providers there.
